Revurdering af antityreoid medicinsk behandling af Graves' sygdom

U F Feldt-Rasmussen, D Glinoer, J Orgiazzi

Abstract

Though antithyroid medical therapy has been used for several decades in the medical treatment of hyperthyroidism, only recently has attention been drawn towards prospective controlled trials concerning the effect in relation to dosage as well as the dosage related to side effects. A review is given in relation to recent investigations on treatment strategies in various parts of the world as well as the most frequently used strategies in Europe. Special attention is given to treatment principles in relation to pregnancy, children and adolescents as well as patients with eye symptoms. Antithyroid drug therapy of hyperthyroidism is a frequent and successful treatment strategy in Europe. Globally, there are still large discrepancies in the treatment strategies, related rather to conventions than to a rational attitude.

Bidragets oversatte titelReevaluation of antithyroid drug therapy in Graves disease
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind157
Udgave nummer1
Sider (fra-til)25-9
Antal sider5
ISSN0041-5782
StatusUdgivet - 2 jan. 1995
Udgivet eksterntJa

Emneord

  • Antithyroid Agents/administration & dosage
  • Europe
  • Evaluation Studies as Topic
  • Graves Disease/drug therapy
  • Humans
  • United States

Fingeraftryk

Dyk ned i forskningsemnerne om 'Revurdering af antityreoid medicinsk behandling af Graves' sygdom'. Sammen danner de et unikt fingeraftryk.

Citationsformater